Status:

RECRUITING

Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.

Lead Sponsor:

Institute for the Care of Mother and Child, Prague, Czech Republic

Collaborating Sponsors:

Bulovka Hospital

General University Hospital, Prague

Conditions:

Asherman Syndrome

Abortion Late

Eligibility:

FEMALE

18-40 years

Phase:

PHASE4

Brief Summary

Only patients who sign an informed consent will be included. Patients after a miscarriage in the 2nd trimester of pregnancy who need to perform an instrumental revision of the uterine cavity (RCUI, re...

Detailed Description

Methodology Only patients who sign informed consent will be included. Patients after a miscarriage in the 2nd trimester of pregnancy who need to perform an instrumental revision of the uterine cavity ...

Eligibility Criteria

Inclusion

  • Adult (18 to 40 years) women with a wish for future pregnancy
  • abortion in the 2nd trimester of pregnancy (over 12 weeks of pregnancy) with instrumental revision of the uterine cavity (RCUI)
  • signed informed consent

Exclusion

  • age below 18 years, age over 40 years
  • history of previous uterine surgery (myomectomy, resection of the intrauterine septum, disruption of intrauterine adhesions)
  • suspected molar pregnancy
  • signs of pelvic infection
  • disagreement with participation in the study

Key Trial Info

Start Date :

September 28 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2025

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04671914

Start Date

September 28 2021

End Date

April 1 2025

Last Update

May 13 2024

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

1.Lf Uk, Vfn

Prague, Czechia, 12000

2

Instiue for Care of Moher and Childe

Prague, Czechia, 14000

3

FN Bulovka

Prague, Czechia, 14800